Search Results for: size of market

At 21.5% CAGR, CBD Oil Market Size & Share | Cannabidiol Oil Industry Report, 2020-2025 | Covid-19 Impact Analysis

In its latest report on CBD Oil Market provides a concise analysis of the recent market trends. The report further includes statistics, market forecasts and revenue estimations, which in addition highlights its status in the competitive domain as well as expansion trends adopted by major industry players.

Cannabidiol Oil (CBD Oil) Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025.Cannabidiol Oil Market is valued at USD 23.37 Million in 2018 and expected to reach USD 1068.54 Million by 2025 with the CAGR of 21.5% over the forecast period.

Get sample of this report.

The detailed market intelligence report on the Global Cannabidiol Oil (CBD Oil) Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Cannabidiol Oil (CBD Oil) Market place for the forecast 2019- 2025.

Vermont Governor Phil Scott OKs Bill Creating Regulated Cannabis Market

VERMONT: Governor Phil Scott today announced action on a range of bills, including the Legislature’s bill to create a regulated cannabis market in Vermont, which will be allowed to go into law without his signature.

Throughout the Legislature’s four-year push to create a regulated cannabis market, Governor Scott has consistently called for any legislation to include a plan and funding for expanded education and prevention programs for Vermont kids, a plan for highway safety and the ability for communities to prohibit retail cannabis businesses. Governor Scott said the Legislature has moved slowly toward his position in these areas.

“This new bill requires cities and towns to authorize these businesses before retail establishments may open. It ensures local zoning applies to cannabis cultivation and production. It dedicates 30% of the excise tax, up to $10 million per year, to education and prevention efforts. And the sales and use tax on cannabis would fund a grant program to expand after school and summer learning programs,” the Governor said. “Additionally, the FY21 budget includes language I proposed to move toward a universal after school network, which is based on a successful model from Iceland and is focused on preventing drug use and improving academic and social outcomes.”

The Governor also highlighted several new provisions to enhance safety on the roadways, including allowing testimony of trained officers and Drug Recognition Experts regarding impairment to be presumed admissible in court, and accepting saliva testing as evidence if performed.

Though these provisions addressed many of Governor Scott’s longstanding concerns, he also called for additional action from the Legislature to address remaining deficiencies in the bill.

“Their work is not done,” he said. “The Legislature needs to strengthen education and prevention – including banning marketing that appeals in any way to our kids – otherwise they are knowingly failing to learn the lessons of the public health epidemic caused by tobacco and alcohol.”

While recognizing that some social justice elements are included in the bill, Governor Scott also noted concerns from communities historically most negatively affected by cannabis enforcement that the bill did not do enough to ensure more equity in this new market. He encouraged legislators to revisit these concerns and work with his Administration and these communities to address them in January.

His letter to the Legislature outlines specific areas for consideration on racial equity, changes to the board appointment timeline and accountability structure, creation of a special fund for education programming and a ban on the sale of vaping products and marketing that appeal to kids.

“This has been a top priority for the majority in the Legislature for four years, but their work is not complete. They must ensure equity in this new policy and prevent their priority from becoming a public health problem for current and future generations. For these reasons, I am allowing this bill to become law without my signature,” concluded Governor Scott.

Click here to view the Governor’s letter to the Legislature regarding S.54.

Governor Scott also allowed S.119 to go into law without his signature, noting he agreed with the goals of the legislation but urged lawmakers to revisit the hastily drafted bill with additional input from marginalized communities and public safety officials.

Click here to view the Governor’s letter to the Legislature regarding S.119.

In addition, Governor Scott signed several other bills today:

  • S.24, An act relating to a report on racial equity and bias in the Department of Corrections, which accelerates work to develop a racial equity plan that will include data collection, employment and supervision of people under the custody of the Department of Corrections;
  • S. 124, An act relating to governmental structures protecting the public health, safety and welfare, which makes changes to law enforcement training and policy;
  • S.234, An act relating to miscellaneous judiciary procedures, which orders the expungement of all criminal records relating to the possession of cannabis in amounts that have been decriminalized; and
  • S.352, An act relating to making certain amendments to the Front-Line Employees Hazard Pay Grant Program, which updates the hazard pay program passed earlier this year.

To view a complete list of action on bills passed during the 2020 legislative session, visit https://governor.vermont.gov/governor-scotts-blog/2020-legislative-session.

Anavii Market Offers Brand New Line Of Martha Stewart CBD Products

​Anavii Market, a premier online retailer of verified CBD oil, today announced the unveiling of a much-anticipated brand of Martha Stewart CBD. The new collection consists of six unique hemp products, including CBD tinctures, gummies and softgels, all developed and curated by Martha Stewart herself in partnership with Canopy Growth Corporation.

This is the first-ever CBD product launch by the lifestyle enthusiast in collaboration with Canopy Growth, which is a world-renowned CBD company.

Anavii Market is thrilled to team up with Canopy Growth in selling Martha Stewart’s brand new collection of CBD oil.

“Bringing quality and pure hemp wellness products to America is our mission at Anavii Market, and we are happy to partner with Martha and Canopy to help spread the good news about CBD to their networks,” said Jason Amatucci, co-founder of Anavii Market.

Starting today, customers are able to enjoy the exciting new flavors that Martha Stewart specially designed herself. This new range of products incorporates the most flavorful side of CBD, as well as Martha’s drive to create only the best quality products made from the purest hemp.

Buyers are welcomed to try Martha Stewart CBD Tincture, which is a concentrated blend of CBD oil extracted from the highest quality hemp. CBD tinctures are easy to use and designed to distribute a specific amount of CBD per serving. Each serving contains 25 mL of two exciting, citrusy flavors. These include blood orange and Meyer lemon.

Anavii Market is also offering a delicious assortment of Martha Stewart CBD Gummies. Infused with 99% pure CBD isolate per gummy, these tasty, chewable treats come in two fruit medleys of berry and citrus, and are the perfect size to carry anywhere you go.

Made with only the finest ingredients, Martha Stewart CBD Softgels offer the best quality and consistency of CBD oil on the market. Each softgel contains 25mg of CBD and is made with non-GMO, coconut-derived MCT oil and pure-hemp derived CBD isolate.

All Martha Stewart CBD products have been rigorously lab-tested to ensure that the products contain zero heavy metals, pesticides, solvents and other toxins.

Consumers can purchase each Martha Stewart CBD product through Anavii Market’s online store and get a 20% off discount for a limited time. For more information and updates about the Martha Stewart CBD product launch, follow the Anavii Market blog today.

FSD Pharma To Begin Trading On The NASDAQ Capital Market Under Symbol ‘HUGE’ January 9, 2020

FSD Pharma

CANADA: FSD Pharma Inc. today announced that its Class B Subordinate Voting Shares (the “Shares”) have been approved for listing on the NASDAQ Capital Market under the symbol ‘HUGE’. Trading on the NASDAQ is expected to commence at market open on Thursday, January 9, 2020.

The Company’s Shares will continue to be listed on the Canadian Securities Exchange under the symbol ‘HUGE’.

“As we announce this much anticipated and coveted milestone, I want to congratulate the FSD Pharma team, our stakeholders, and, most importantly, our shareholders. I also want to extend my gratitude to the members of the Board of Directors of FSD Pharma, and especially to the founders of the Company, for their vision and for giving me an opportunity to lead the FSD Pharma team to achieve this strategic advantage. It is exciting to realize that once we begin trading on NASDAQ, we will be included in a select group of 12 Canadian-domiciled cannabis companies trading on either the NYSE or NASDAQ, and the first company in the history of the Canadian Securities Exchange to be dual-listed on a major U.S. exchange,” stated Raza Bokhari, MD, Executive Co-Chairman and CEO.

 

CBD For Anxiety: The Best Products on the Market Today

Health enthusiasts attest to the broad range of CBD benefits that hemp-derived products provide. While more scientific research is encouraged, the existing research, as well as the anecdotal evidence from users, suggests that cannabidiol is an excellent pharmaceutical alternative for treating ailments like pain, anxiety, depression, and more–for example, the FDA has approved a CBD product called Epidiolex, which treats two kinds of pediatric epilepsy.

CBD products come in many forms, you can smoke CBD via vaporizer, apply it to the skin topically, ingest it in edible forms like gummies, and much more.

Arguably the most popular consumption methods are oils and tinctures, which you typically take sublingually. However, depending on how they are produced and what other ingredients are mixed in, oils and tinctures can carry earthy tastes that some customers are not fond of. Gummies, however, are a fun way to ingest CBD for pain relief and other maladies with an assortment of different flavors.

Here are a few of the best CBD products for anxiety on the market today.

Verma Farms

 

Verma Farms grows its own organic hemp and does not use pesticides. Because hemp is a bio-accumulator—meaning it absorbs other substances from its environment, such as toxins that may seep into the soil—unwanted and even harmful ingredients can sneak their way into CBD products. However, Verma does not use such toxins in its growing process and has a third-party lab test its products for purity and potency before selling them (the company also publishes the lab results online). If you want trustworthy CBD isolate products—including the best CBD oil on the market— Verma Farms is worth checking out.

Verma Farms Oil

Cannabidiol Life

 

Cannabidiol Life is based in Denver, Colorado, manufactures all of its products in-house, and is frequently inspected by the Denver Department of Health to assure quality and purity.

 

CBD Oil Geek recommends Cannabidiol Life because not only are they high-quality, but their gummies come in delicious flavors without hempy aftertastes–such as Golden Maple and Chocolate Bliss. In addition, their products come in a variety of dosages and are reasonably priced!

 

The company’s gummies use CBD isolate, but they also sell a range of other full-spectrum products. Cannabidiol Life is an excellent option if you want your CBD to come in playful shapes like worms or bears—but make sure to keep them away from children!

cbd-gummy-worms-for-sale

Green Roads

Green Roads is a renowned CBD company that sells high-quality, pharmacist-formulated products that are third-party lab tested and created from hemp grown in the US. Their website sums up what makes their gummies great,

“[Green Roads products have] universal appeal in that they offer a simple and discreet way to get your daily dose of CBD. Besides their fun and colorful appearance and fruity taste, these edibles contain all of the benefits of CBD, making them an excellent option for people looking for long-term relief over a short-term fix.”

Green Roads products are known to be highly effective and provide a host of options that range from gummies and syrups to pain cream and tea. If you want to make taking CBD a bit more fun and flavorful, Green Roads gummies are a good option.

 

CBD Edibles

Pure Kana

 

Pure Kana is a company that sells potent CBD isolate gummies—and they are vegan! An aspect that you can find with a variety of oils, but not always with edibles.

 

Each gummy has 25mg of cannabidiol and comes in natural fruit flavors. Experiencing symptoms of anxiety, depression, and pain is not limited to particular times, so Pure Kana gummies are perfect for taking CBD on the go–especially if you are hesitant or feel uncomfortable ingesting oil via a dropper in the middle of the day or in public.

CBD-Gummies-min

CBDistillery

CBDistillery offers gummies with 30mg of CBD per candy. They contain no THC, and independent test results are visible online.

CBDistillery-Gummies_DAY-1

Koi CBD

According to Koi CBD’s website:

“Unlike most CBD gummies—which spray CBD on their products—Koi takes the extra time to mix and roll our full-spectrum CBD blend into our gummies three times. Why? It evenly distributes the CBD throughout each piece, giving you the consistency and effectiveness that you deserve.”

Koi’s gummies come in flavors like tangerine, lime, and acai pomegranate. The company’s processes ensure that each piece is just as effective as any other, and their full-spectrum blend enhances the health benefits you are looking for.

Koi-CBD-Gummies

Why choose CBD Gummies?

If you are looking for the CBD for pain relief or other ailments but want to take doses whenever you want that don’t taste “hempy,” gummies might be the perfect option for you.

What are your favorite CBD gummies, and which ones are you interested in trying? Let us know in the comments below!

Cresco Labs Enters Florida – Will Have Access to 65% Of The Total Addressable U.S. Cannabis Market

ILLINOIS: Cresco Labs Inc., one of the largest vertically integrated multi-state cannabis operators in the United States, today announced that it is entering the Florida market through the signing of a letter agreement to acquire the ownership interests or assets of VidaCann Ltd. and/or affiliated entities, one of the largest and most advanced providers of medical cannabis in Florida.

Key Transaction Highlights and Benefits:

  • Vertically Integrated Florida License – Provides Cresco Labs a Medical Marijuana Treatment Center license to grow, process, manufacture, distribute and dispense the Company’s house of branded products in up to, currently, 30 retail medical dispensaries in the state of Florida.
  • Retail Dispensary Footprint & Rollout – VidaCann currently operates seven (7) dispensaries in the cities of Bradenton, Deerfield Beach, Holly Hill, Orlando, Palm Bay, St. Petersburg, and Tampa and expects to have 14 dispensaries open by the end of June 2019.
    • Additional dispensary locations in Tallahassee, Bonita Springs and Port Charlotte are completed and pending operational approval, and locations in Jacksonville, West Palm Beach, Miami and Pensacola are currently under construction and scheduled to open by the end of June 2019.
    • VidaCann is projected to have up to 20 dispensaries by the end of 2019, while Cresco intends to further accelerate the VidaCann retail dispensary rollout. Dispensary locations are strategically located throughout the state to ensure 95% of the population of Florida is within 50 miles of a VidaCann dispensary. Delivery is available statewide to all licensed patients.
  • Operational Cultivation and Processing – A fully-operational, greenhouse cultivation facility with a state-of-the-art cGMP-certified processing and analytical lab, meeting all FDA requirements.
    • Fully operational 70,000 ft2 cultivation and processing facility is scheduled to double in size by the end of 2019 and will allow Cresco Labs to grow and manufacture its full suite of branded products for distribution across the state.
    • The greenhouse maintains more than 30 premium strains and VidaCann is the only Florida cannabis company using custom-made Italian extractors that can process over 400 pounds a day.

Management Commentary:

“Entering the Florida market is consistent with Cresco Labs strategy of entering markets with outsized demand with strong regulatory structures and is an important milestone for the Company that dramatically impacts our growth trajectory and will be accretive to our earnings in 2019,” said Cresco Labs CEO and Co-founder Charlie Bachtell. “Since relaunching its cannabis program in 2017, Florida has seen tremendous growth in patient registration and is one of the most important markets in the country. VidaCann is the perfect blend of an established operational footprint and infrastructure of professionals that will allow Cresco to execute its disciplined and strategic Florida plan expeditiously.” Bachtell added, “We look forward to welcoming all of the 100 VidaCann employees to the Cresco Labs family.”

“Matching our proven ability to execute operationally with unparalleled speed to the foundation already established by VidaCann, we expect to efficiently scale our Florida operations, immediately impact the market, and get the same high rate of market share that we have achieved in other states in which we operate. We are excited to bring the Cresco Labs’ brand of professional cannabis to the patients of Florida and to all stakeholders involved with this program,” said Cresco Labs President and Co-founder Joe Caltabiano.

Florida Market:

According to Arcview Market Research/BDS Analytics, the medical cannabis market in Florida is projected to increase to $1.7 billion by 2022 primarily based on increasing patient count – there are now currently more than 2,000 qualified ordering physicians and nearly 200,000 registered patients (upon 200,000 patients, VidaCann will have the ability to increase its dispensaries to 35) with total medical patients estimated to reach 550,000 by 2022. With a population of approximately 21 million, the Florida market will increase Cresco Labs’ total addressable consumer base to more than 140 million people.

Cresco Labs Footprint:

Upon the closing of the Transaction, Cresco Labs will have 14 production facilities and 21 retail dispensaries operating with licenses to operate a total of 51 retail dispensaries across 10 states – Illinois, Pennsylvania, Ohio, Nevada, California, Arizona, Florida with New York, Maryland and Massachusetts pending approval. The Company’s products are currently on the shelves of over 250 dispensaries. Cresco Labs is operational in six of the seven most populated states in the country and has more than 140 million potential consumers which is 65% of the estimated total addressable US cannabis market.

Transaction Details:

The purchase consideration is approximately $120 million and will be comprised of a mix of Cresco Labs shares, which will be subject to a 6 to 12-month lock-up agreement following closing, and cash. The final purchase price and proportion of cash and stock to be determined and reflected in the definitive agreement.

Completion of due diligence and execution of a definitive transaction agreement is expected within two weeks. The Transaction is anticipated to close during the second quarter and will be subject to customary closing conditions, including approval from the CSE, the Florida Department of Health and all applicable U.S. regulatory agencies.

VidaCann has been operational since 2018 and their year-end financials have not yet been finalized.

Cresco Labs Shares Approved to Trade on the OTC Markets under the Symbol ‘CRLBF’

ILLINOIS: Cresco Labs, one of the largest vertically integrated multi-state cannabis operators in the United States, announced that its shares have been approved to be quoted on the Over-the-Counter Market (OTC) and will trade under the symbol “CRLBF,” effective immediately. Cresco has applied to trade its shares to the OTCQX Market, the top tier of the three markets for the over-the-counter trading of stocks.

Cresco-Logo_Blue“Trading on a U.S. market is important because investors now have direct access to invest in Cresco Labs and to support our mission of normalizing and professionalizing the cannabis industry,” said Cresco Labs CEO and Co-founder Charlie Bachtell.

Cresco Labs was approved for listing on the Canadian Securities Exchange (“CSE”) on Friday, November 30, 2018 and began trading on the CSE under the ticker symbol “CL” on Monday, December 3, 2018.

MJBA Founder David Rheins Picks The Hottest Hemp, CBD, Vape & Culture+ Products Of 2019 At ASD Market Week | Culture+

VIP Panel Will Include Founders of Elixinol, The Blinc Group, Curved Papers and Farmer Tom Hemp Co.

NEVADA: The Culture+ marketplace is exploding, with thousands of new legal hemp, CBD, vape and cannabis-culture products creating consumer excitement and marketplace disruption.

MJBA at ASD

MJBA’s founder and executive director David Rheins, a seasoned marketing executive who learned his chops playing senior roles for Rolling Stone, SPIN, Time Warner AOL, has scoured the country to find The Hottest Hemp, CBD & Culture+ Products of 2019, which he’ll present at the ASD Market Week | Culture+ convention in Las Vegas on Monday, March 18, 9:00 AM – 9:45 AM.

Screenshot 2018-12-10 16.46.33These are the products that every retailer must know about – from hemp-based fashions and CBD health and beauty aids, to the latest in vaporizer technology and glassware.

Screenshot 2018-12-10 14.26.21

Following the 45-minute presentation, moderator David Rheins will lead a VIP Panel Discussion with the brand marketers who are building the industries best and most innovative brands, including Elixinol co-founder David Newman, The Blinc Group CEO Sasha Aksenov, Farmer Tom Hemp Co. Founder Tom Lauerman, and Curved Papers Founder Michael O’Malley.

Hemp is projected to be a $22 Billion market by 2012. Get an advanced look at all the hottest products, trends and technologies driving the red-hot Culture+ market.

Registration for the show is available online.

Up Cannabis To launch first Experiential Hub In Ontario Market

CANADA: Newstrike Brands, and its wholly-owned subsidiary, Up Cannabis Inc., announce that an Up Cannabis “Experiential Hub” will be featured prominently in Ontario’s first Spiritleaf store, expected to be located in Kingston, Ontario, in connection with a retail agreement entered into between Spiritleaf and a Ontario cannabis retail lottery winner.

Newstrike Brands Ltd--Up Cannabis to launch first Experiential H

Inner Spirit Holdings (“Inner Spirit”) (CSE: ISH) announced earlier today that Inner Spirit’s subsidiary, Spirit Leaf Inc., has entered into an agreement with one of the initial 25 cannabis retail lottery winners in Ontario to open a Spiritleaf cannabis retail store in Kingston.

The Spiritleaf store—the company’s first in the Ontario market—is planned to be located on Princess Street, in the heart of Kingston, and will feature an Up Cannabis Experiential Hub, or a “store-within-a-store,” designed to complement existing Spiritleaf design elements and provide education about cannabis, while showcasing both companies’ love of music and various community and charitable endeavors. An opening date of April 1st is targeted, to coincide with the launch of cannabis retail stores throughout Ontario.

“We are thrilled to partner with Spiritleaf and look forward to seeing an Up Cannabis Experiential Hub in one of the first retail stores in the province,” said Jay Wilgar, CEO of both Newstrike and Up Cannabis. “Up Cannabis’ ties to Kingston run deep as the hometown of our partners, The Tragically Hip, with many special milestones in our company’s history taking place there, and more to come. We’re excited to see the stars aligning for both our brands as the Ontario retail marketplace takes shape.”

The news follows the investment agreement and strategic alliance agreement entered into between Newstrike and Inner Spirit whereby each of the companies acquired equity interests in each other and provides for the retail distribution of Up Cannabis products and the creation and operation of Up Cannabis-branded customer lounges or Experiential Hubs in Spiritleaf stores, as regulations allow.   Inner Spirit currently has four Spiritleaf retail franchise stores with Up Cannabis Experiential Hubs currently operating in Alberta and Saskatchewan with a fifth outlet scheduled to open Calgary on February 14, 2019.

Cura Partners Enters European Market With Plata Wellness To Distribute Select CBD Brand

UNITED KINGDOM: Cura Partners, one of the largest cannabis and hemp-based CBD consumer products companies in the world, is officially entering the European market (EU) through a distribution agreement with Plata Wellness.

CuraThe agreement allows Cura’s Select CBD products to be available direct to consumers in legal markets across Europe via the website www.selectcbd.eu. Cura has appointed Plata Wellness Limited (Plata) to assist with its entry into the EU. In addition to Plata’s role as Cura’s inaugural overseas distributor, Plata is also providing a number of other services including order fulfillment, payment processing, and in the future, licensing and manufacturing. This partnership begins with the introductions of Select’s CBD disposable vaporizer cartridges but will, over time, add other legal consumer products including tinctures, gel caps and muscle rubs.

“Cura’s decision to move into Europe is in direct alignment with the company’s mission to be the leading provider of cannabis oil to consumers and brands in legal U.S. and international markets,” said President and Chief Executive Officer Cameron Forni. “I’m proud of the team that made this possible, and look forward to partnering with Plata Wellness to get the Select CBD brand into the hands of consumers across Europe.”

Europe is home to more than 741 million people, more than double the combined population of the United States and Canada. When trying to extrapolate these numbers to account for the potential demand in Europe’s much larger population, there is a crystal-clear reason why established cannabis companies in the United States are now turning their attention to Europe.

“We are delighted to have partnered with Cura, the market leading company in this sector. We are excited to work together to bring the Select brand to prominence in Europe and to supply consumers with these award-winning products,” said Jon Robson, Managing Director at Plata Wellness Limited.

Consumers in the United Kingdom can purchase Select CBD Blends vape pens online at www.selectcbd.eu with additional products coming soon.